Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves new pain medicine
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.
Rolling Out
8d
7 treatments that help you manage constant pain
Revolutionary medical treatments offer new hope for chronic pain sufferers through advanced technology, targeted medications ...
Psychology Today
1d
Treating Pain—Avoiding the Brain
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
TheHealthSite
26m
The Connection Between Leprosy And Chronic Pain: A Neurological Insight
It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.
10d
on MSN
New guidelines address pain treatment infections
The first comprehensive guidelines dedicated to minimizing infections in patients undergoing surgeries and procedures ...
NOLA.com
2d
Get Back in the Game: Managing Knee Pain with ZILRETTA®
For active New Orleanians, knee osteoarthritis (OA) pain can sideline even the most passionate participants. Whether it’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback